NCT07067619 Pain Acceptance Training in Patients Experiencing Emotional Distress and Somatic Symptoms: Examination of Dialectical Thinking as a Mediating Factor
| NCT ID | NCT07067619 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Haifa |
| Condition | Chronic Pain |
| Study Type | INTERVENTIONAL |
| Enrollment | 100 participants |
| Start Date | 2024-12-01 |
| Primary Completion | 2026-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 100 participants in total. It began in 2024-12-01 with a primary completion date of 2026-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Somatic symptoms, including physical pain, are highly prevalent among mental health patients. Current treatments have limited effectiveness for these symptoms, primarily because of patients' diminished introspective capacity and lack of emotional awareness. The current study proposes pain acceptance training as a new intervention. This intervention relies on the tenets of dialectical thinking, particularly on maintaining a dialectic perspective - at once acknowledging both the desire to end the pain and the ability to accept it as it is. We aim to examine the following: (1) the efficacy of pain acceptance training in the alleviation of somatic pain in patients with somatic symptoms; (2) the role of dialectical thinking as a mediator of pain acceptance training efficacy.
Eligibility Criteria
Inclusion Criteria: 1. Men and Women 2. Aged 18-70 3. Able to provide a signed informed consent 4. Experiencing significant pain symptoms that interfere with daily-life functioning 5. Experiencing significant emotional distress symptoms Exclusion Criteria: Patients under the age of 18 and/or diagnosed with one or more of the following diagnoses will be excluded from participation in the study: 1. Patients rating their average pain in the last week and in the last month as less than 3 in a 0-10 numerical rating scale (i.e. NPS) 2. Patients rating their emotional distress levels as less than 25 in a 10-50 numerical rating scale (i.e. Kessler Psychological Distress Scale \[K10\]) 3. Patients diagnosed with psychotic disorders and/or suffering from psychotic symptoms. 4. Patients diagnosed with Autism Spectrum disorder. 5. Patients diagnosed with Intellectual disability. 6. Patients diagnosed with eating disorders. 7. Patients with Immediate suicidal risk. 8. Patients who initiated a new drug and/or psychotherapy treatment within the last month. 9. Pregnant women. 10. Patients currently serving in the IDF.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07067619 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 70 Years, studying Chronic Pain. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07067619 currently recruiting?
Yes, NCT07067619 is actively recruiting participants. Contact the research team at s_grinapol@rambam.health.gov.il for enrollment information.
Where is the NCT07067619 trial being conducted?
This trial is being conducted at Haifa, Israel, Haifa, Israel.
Who is sponsoring the NCT07067619 clinical trial?
NCT07067619 is sponsored by University of Haifa. The trial plans to enroll 100 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.